Summary
Pfizer Inc. (PFE) announced a key change to its Board of Directors in an 8-K filing dated April 1, 2020, effective March 31, 2020. Dr. Susan Desmond-Hellmann has been elected as a new member of the Board, bringing her extensive experience to the company. This appointment is significant as it adds a new perspective and expertise to the governance and strategic direction of Pfizer.
Key Highlights
- 1Dr. Susan Desmond-Hellmann elected to Pfizer's Board of Directors.
- 2Effective date of appointment: April 1, 2020.
- 3Dr. Desmond-Hellmann appointed to the Governance & Sustainability Committee.
- 4Dr. Desmond-Hellmann appointed to the Science and Technology Committee.
- 5Standard compensation and indemnification agreement for non-employee directors will apply.
- 6A press release dated April 2, 2020, announcing the election is included as an exhibit.